The latest European sample survey of public perceptions of biotechnology reveals widespread opposition to genetically modified (GM) food in much of Europe, but public attitudes to medical and environmental applications remain positive.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Fogging to combat dengue: factors influencing stakeholders' attitudes in Malaysia
BMC Public Health Open Access 14 June 2023
-
“To do, or not to do?”: determinants of stakeholders’ acceptance on dengue vaccine using PLS-SEM analysis in Malaysia
BMC Public Health Open Access 19 August 2022
-
Determinants of stakeholders’ attitudes and intentions toward supporting the use of Wolbachia-infected Aedes mosquitoes for dengue control
BMC Public Health Open Access 23 December 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
Gaskell, G et al. Europe ambivalent on biotechnology. Nature 387, 845–847. (1997).
Durant, J., Bauer, M.W. & Gaskell, G. Biotechnology in the public sphere: a European source book. (Science Museum Press, London; 1998).
Schuman, H. & Presser, S. Public opinion and public ignorance: the fine line between atttitudes and non-attitudes. Am. J. Sociol. 85, 1214–1225 ( 1980).
Acknowledgements
This article was written with support of the European Commission, Research Directorate-General (QLRT-1999-00286).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gaskell, G., Allum, N., Bauer, M. et al. Biotechnology and the European public. Nat Biotechnol 18, 935–938 (2000). https://doi.org/10.1038/79403
Issue Date:
DOI: https://doi.org/10.1038/79403